Disc Medicine, Inc.
IRON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816736
In the last 90 days, Disc Medicine, Inc. insiders filed 0 open-market purchases and 11 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $3.13B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Disc Medicine, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- −5 vs. Q1 2022
- Shares held
- 25.9M
- −2.55M (−9.0%) vs. Q1 2022
- Total value
- $43.8M
- +$4.25M (+10.8%) vs. Q1 2022
- New holders
- 14
- 8 more added
- Sold out
- 19
- 16 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $3.13B |
| Q1 2026 | 203 | $2.67B |
| Q4 2025 | 197 | $3.04B |
| Q3 2025 | 168 | $2.26B |
| Q2 2025 | 152 | $1.80B |
| Q1 2025 | 157 | $1.65B |
| Q4 2024 | 152 | $1.68B |
| Q3 2024 | 132 | $1.35B |
| Q2 2024 | 121 | $1.24B |
| Q1 2024 | 130 | $1.38B |
| Q4 2023 | 112 | $1.17B |
| Q3 2023 | 91 | $934.0M |
| Q2 2023 | 90 | $848.7M |
| Q1 2023 | 45 | $309.6M |
| Q4 2022 | 35 | $215.8M |
| Q3 2022 | 44 | $43.9M |
| Q2 2022 | 51 | $43.8M |
| Q1 2022 | 57 | $39.6M |
| Q4 2021 | 62 | $93.8M |
| Q3 2021 | 62 | $103.5M |
| Q2 2021 | 55 | $165.3M |
| Q1 2021 | 49 | $346.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Disc Medicine, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 5,826,224 | $9.85M | 0.19% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,254,365 | $8.88M | 1.48% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 2,435,125 | $4.12M | 2.87% | 00.0% | Unchanged |
| Foresite Capital Opportunity Management V, LLC | 2,435,125 | $4.12M | 10.37% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 2,372,267 | $4.01M | 0.15% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,300,000 | $2.20M | 0.14% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 882,612 | $1.49M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 762,163 | $1.29M | 0.00% | +225,961+42.1% | Added |
| Vanguard Group Inc | 696,264 | $1.18M | 0.00% | −44,539−6.0% | Reduced |
| Citadel Advisors LLC | 566,968 | $958.0K | 0.00% | +225,558+66.1% | Added |
| Ikarian Capital, LLC | 443,096 | $749.0K | 0.31% | 00.0% | Unchanged |
| FMR LLC | 395,684 | $669.0K | 0.00% | −1,662−0.4% | Reduced |
| K2 Principal Fund, L.P. | 292,745 | $495.0K | 0.08% | +292,745 | New |
| Renaissance Technologies LLC | 280,600 | $474.0K | 0.00% | −70,500−20.1% | Reduced |
| Geode Capital Management, LLC | 271,115 | $458.0K | 0.00% | −160,210−37.1% | Reduced |
| Harvard Management Co Inc | 250,000 | $423.0K | 0.05% | 00.0% | Unchanged |
| BlackRock Inc. | 214,025 | $361.0K | 0.00% | −1,086,179−83.5% | Reduced |
| Bank of Montreal | 150,393 | $276.0K | 0.00% | +150,393 | New |
| UBS Group AG | 138,470 | $234.0K | 0.00% | +138,470 | New |
| Ergoteles LLC | 106,100 | $179.0K | 0.01% | +106,100 | New |
| State Street Corp | 101,899 | $172.0K | 0.00% | −306,805−75.1% | Reduced |
| Stifel Financial Corp | 93,621 | $158.0K | 0.00% | −10,200−9.8% | Reduced |
| Marquette Asset Management, LLC | 87,648 | $148.0K | 0.04% | +21,379+32.3% | Added |
| Crestline Management, LP | 61,701 | $104.0K | 0.01% | −799−1.3% | Reduced |
| Citigroup Inc | 51,093 | $86.0K | 0.00% | +50,175+5,465.7% | Added |
| Northern Trust Corp | 48,645 | $82.0K | 0.00% | −146,695−75.1% | Reduced |
| Bridgeway Capital Management, LLC | 47,500 | $80.0K | 0.00% | −70,000−59.6% | Reduced |
| Boothbay Fund Management, LLC | 42,297 | $71.0K | 0.00% | 00.0% | Unchanged |
| Fiduciary Trust Co | 40,510 | $68.0K | 0.00% | +40,510 | New |
| Goldman Sachs Group Inc | 36,635 | $62.0K | 0.00% | +16,297+80.1% | Added |
| Prelude Capital Management, LLC | 31,099 | $53.0K | 0.00% | −64−0.2% | Reduced |
| Morgan Stanley | 30,985 | $53.0K | 0.00% | +33+0.1% | Added |
| Susquehanna International Group, LLP | 29,002 | $49.0K | 0.00% | +12,369+74.4% | Added |
| Diametric Capital, LP | 27,563 | $47.0K | 0.03% | +27,563 | New |
| Virtu Financial LLC | 20,530 | $35.0K | 0.00% | +20,530 | New |
| MYDA Advisors LLC | 20,000 | $34.0K | 0.01% | +20,000 | New |
| Qube Research & Technologies Ltd | 18,610 | $31.0K | 0.00% | +18,610 | New |
| Assenagon Asset Management S.A. | 15,704 | $27.0K | 0.00% | +15,704 | New |
| Bank of New York Mellon Corp | 11,008 | $19.0K | 0.00% | −58,070−84.1% | Reduced |
| Penserra Capital Management LLC | 11,369 | $19.0K | 0.00% | +1,395+14.0% | Added |
| Running Point Capital Advisors, LLC | 10,000 | $17.0K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,837 | $13.0K | 0.00% | −531−6.3% | Reduced |
| Ulland Investment Advisors, LLC | 348 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 148 | $0 | 0.00% | −47,555−99.7% | Reduced |
| Bank of America Corp | 240 | $0 | 0.00% | −6,901−96.6% | Reduced |
| New York State Common Retirement Fund | 201 | $0 | 0.00% | −1,000−83.3% | Reduced |
| TCI Wealth Advisors, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 12 | $0 | 0.00% | +12 | New |
| Simplex Trading, LLC | 499 | $0 | 0.00% | +499 | New |
| Capital Advisors, Ltd. LLC | 68 | $0 | 0.00% | +68 | New |
| Ellevest, Inc. | 106 | $0 | 0.00% | +106 | New |
| Franklin Resources Inc | 0 | $0 | 0.00% | −1,071,790−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −496,120−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −115,213−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −80,679−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −46,453−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −17,304−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −15,226−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −11,893−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −10,875−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −10,274−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −10,301−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −9,679−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −5,100−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −3,559−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,897−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −2,432−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,572−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −1,718−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |